Literature DB >> 3014038

An HLA-D region restriction fragment length polymorphism associated with celiac disease.

M D Howell, R K Austin, D Kelleher, G T Nepom, M F Kagnoff.   

Abstract

This study is the first to describe a molecular marker that distinguishes the celiac disease HLA-D region haplotype from a serologically identical haplotype in unaffected controls. Using a DQ beta chain cDNA probe and the restriction endonuclease Rsa I, we have detected a polymorphic 4.0 kb fragment which, in DQw2 individuals, is associated with a 40-fold increased relative risk of developing celiac disease. This finding should permit the identification of the celiac disease susceptibility gene(s) in the HLA-D region and facilitate a more precise dissection of the molecular and immunogenetic mechanisms involved in the pathogenesis of that disease.

Mesh:

Substances:

Year:  1986        PMID: 3014038      PMCID: PMC2188220          DOI: 10.1084/jem.164.1.333

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Evidence that celiac disease is primarily associated with a DC locus allelic specificity.

Authors:  R Tosi; D Vismara; N Tanigaki; G B Ferrara; F Cicimarra; W Buffolano; D Follo; S Auricchio
Journal:  Clin Immunol Immunopathol       Date:  1983-09

4.  Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens.

Authors:  D Larhammar; L Schenning; K Gustafsson; K Wiman; L Claesson; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

5.  DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease.

Authors:  G R Corazza; P Tabacchi; M Frisoni; C Prati; G Gasbarrini
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

6.  Molecular organization of the HLA-SB region of the human major histocompatibility complex and evidence for two SB beta-chain genes.

Authors:  J Gorski; P Rollini; E Long; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing.

Authors:  F Shanahan; R McKenna; C F McCarthy; M I Drury
Journal:  Q J Med       Date:  1982

8.  Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes.

Authors:  E O Long; C T Wake; J Gorski; B Mach
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Mutations and selection in the generation of class II histocompatibility antigen polymorphism.

Authors:  K Gustafsson; K Wiman; E Emmoth; D Larhammar; J Böhme; J J Hyldig-Nielsen; H Ronne; P A Peterson; L Rask
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

10.  Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains.

Authors:  L Schenning; D Larhammar; P Bill; K Wiman; A K Jonsson; L Rask; P A Peterson
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  28 in total

Review 1.  Understanding the molecular basis of coeliac disease.

Authors:  M F Kagnoff
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

2.  Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease.

Authors:  M F Kagnoff; Y J Paterson; P J Kumar; D D Kasarda; F R Carbone; D J Unsworth; R K Austin
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

3.  Genetic control of oral tolerance to ovalbumin in mice.

Authors:  A G Lamont; A M Mowat; M J Browning; D M Parrott
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

Review 4.  Molecular biology and coeliac disease.

Authors:  P D Howdle; G E Blair
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 5.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  Complement C4 types in coeliacs and controls.

Authors:  J Cahill; F M Stevens; C F McCarthy
Journal:  Ir J Med Sci       Date:  1991-06       Impact factor: 1.568

7.  HLA-DP and coeliac disease: family and population studies.

Authors:  C Caffrey; G A Hitman; M J Niven; P G Cassell; P Kumar; L Fry; P Mackintosh; R Gallagher; C Feighery; D Weir
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

8.  Dietary modifications: food dependent autoimmunity in coeliac disease.

Authors:  A M Mowat
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

9.  Studies on the interaction between alpha-gliadin and HLA and T cell receptor molecules in coeliac disease.

Authors:  R B Gallagher; C Feighery; D G Weir; C P Kelly; C A Whelan
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

10.  Major histocompatibility complex antigens in steroid-responsive nephrotic syndrome.

Authors:  P T McEnery; T R Welch
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.